Literature DB >> 11833062

Changing patterns of traumatic bile duct injuries: a review of forty years experience.

Zhi-Qiang Huang1, Xiao-Qiang Huang.   

Abstract

AIM: To summarize the experiences of treating bile duct injuries in 40 years of clinical practice.
METHODS: Based on the experience of more than 40 years of clinical work, 122 cases including a series of 61 bile duct injuries of the Southwest Hospital, Chongqing, and 42 cases (1989-1997) and 19 cases (1998-2001) of the General Hospital of PLA, Beijing, were reviewed with special reference to the pattern of injury. A series of cases of the liver and the biliary tract injuries following interventional therapy for hepatic tumors, most often hemangioma of the liver, were collected. Chinese medical literature from 1995 to 1999 dealing with 2742 traumatic bile duct strictures were reviewed.
RESULTS: There was a changing pattern of the bile duct injury. Although most of the cases of bile duct injuries resulted from open cholecystectomy, other types from other type of trauma such as laparoscopic cholecystectomy (Lc) and hepatic surgery were increased in recent years. Moreover, serious hepato-biliary injuries following HAE using sclerotic agents such as sodium morrhuate and absolute ethanol for the treatment of hepatic hemangiomas were encountered in recent years. Experiences in how to avoid bile duct injury and to treat traumatic biliary strictures were presented.
CONCLUSION: Traumatic bile duct stricture is one of the serious complications of hepato-biliary surgery, its prevalence seemed to be increased in recent years. The pattern of bile duct injury was also changed and has become more complicated. Interventional therapy with sclerosing agents may cause serious hepatobiliary complications and should be avoided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11833062      PMCID: PMC4656625          DOI: 10.3748/wjg.v8.i1.5

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Portal vein embolization by fine needle ethanol injection: experimental and clinical studies.

Authors:  Ming-De Lu; Jun-Wei Chen; Xiao-Yan Xie; Li-Jian Liang; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  [An experimental study of sodium morrhuate as an agent for arterial embolization].

Authors:  Y H Li
Journal:  Zhonghua Fang She Xue Za Zhi       Date:  1987-12

3.  [Interventional therapy of hepatic cavernous hemangioma].

Authors:  X F Yan; J G He; H Z Song
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1994-09

4.  Historical perspectives of biliary tract injuries.

Authors:  J W Braasch
Journal:  Surg Clin North Am       Date:  1994-08       Impact factor: 2.741

5.  Arterial chemoembolization for hepatocellular carcinoma.

Authors:  Jian Fan; Gao-Jing Ten; Shi-Cheng He; Jin-He Guo; Dong-Pei Yang; Guo-Ying Wang
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

6.  The long-term outcome of hepaticojejunostomy in the treatment of benign bile duct strictures.

Authors:  A Tocchi; G Costa; L Lepre; G Liotta; G Mazzoni; A Sita
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

7.  Mechanisms of major biliary injury during laparoscopic cholecystectomy.

Authors:  A M Davidoff; T N Pappas; E A Murray; D J Hilleren; R D Johnson; M E Baker; G E Newman; P B Cotton; W C Meyers
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

8.  Open cholecystectomy. A contemporary analysis of 42,474 patients.

Authors:  J J Roslyn; G S Binns; E F Hughes; K Saunders-Kirkwood; M J Zinner; J A Cates
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

9.  Postcholecystectomy bile duct strictures. Management and outcome in 130 patients.

Authors:  W C Chapman; A Halevy; L H Blumgart; I S Benjamin
Journal:  Arch Surg       Date:  1995-06

10.  Corrective treatment and anatomic considerations for laparoscopic cholecystectomy injuries.

Authors:  J R Madariaga; S F Dodson; R Selby; S Todo; S Iwatsuki; T E Starzl
Journal:  J Am Coll Surg       Date:  1994-09       Impact factor: 6.113

View more
  7 in total

1.  Mechanism of benign biliary stricture: a morphological and immunohistochemical study.

Authors:  Zhi-Min Geng; Ying-Min Yao; Qing-Guang Liu; Xin-Jie Niu; Xiao-Gong Liu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

2.  Experience using liver transplantation for the treatment of severe bile duct injuries over 20 years in Argentina: results from a National Survey.

Authors:  Victoria Ardiles; Lucas McCormack; Emilio Quiñonez; Nicolás Goldaracena; Juan Mattera; Juan Pekolj; Miguel Ciardullo; Eduardo de Santibañes
Journal:  HPB (Oxford)       Date:  2011-06-24       Impact factor: 3.647

3.  Association of Video Completed by Audio in Laparoscopic Cholecystectomy With Improvements in Operative Reporting.

Authors:  Özgür Eryigit; Floyd W van de Graaf; Vincent B Nieuwenhuijs; Meindert N Sosef; Eelco J R de Graaf; Anand G Menon; Marilyne M Lange; Johan F Lange
Journal:  JAMA Surg       Date:  2020-07-01       Impact factor: 14.766

4.  Ultrasonography guided percutaneous radiofrequency ablation for hepatic cavernous hemangioma.

Authors:  Yan Cui; Li-Yan Zhou; Man-Ku Dong; Ping Wang; Min Ji; Xiao-Ou Li; Chang-Wei Chen; Zi-Pei Liu; Yong-Jie Xu; Hong-Wen Zhang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

5.  Liver transplantation: the last measure in the treatment of bile duct injuries.

Authors:  Eduardo de Santibañes; Victoria Ardiles; Adrian Gadano; Martin Palavecino; Juan Pekolj; Miguel Ciardullo
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Bile duct injuries following laparoscopic cholecystectomy: A clinical study.

Authors:  Waheeb R Al-Kubati
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

7.  Clinical significance of galectin-3 expression in malformed hepatic venous tissue.

Authors:  Junbo Qiao; Yongwei Chen; Changxian Dong; Jin Li
Journal:  Indian J Med Res       Date:  2018-12       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.